Glucose Monitoring in Youth with Cystic Fibrosis During Pulmonary Exacerbations (GeM-PEx) (H-54422)

This study aims to assess the prevalence and role of abnormal glucoses in youth with cystic fibrosis during pulmonary exacerbations using continuous glucose monitoring.

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).  

Inclusion criteria: 

1. Ages 6 years to 25 years old
2. Confirmed diagnosis of CF based on sweat chloride ≥ 60 mmol/L and/or two known disease-causing CF mutations
3. Access to a smart phone and/or internet connection and the ability to complete remote telehealth visits

Exclusion criteria:

1. Known type 1 or type 2 diabetes, monogenic diabetes (MODY)
2. Critical illness requiring admission to the intensive care unit
3. Pregnancy